Nanotechnology: Current Applications, Safety Issues and Future Prospects in Veterinary Pharmacology and Toxicology
Abstract
Nanotechnology has emerged as one of the most promising advancements in modern pharmaceutical sciences due to its ability to manipulate materials at the nanoscale and enhance their interaction with biological systems. In veterinary pharmacology and toxicology, nanotechnology offers innovative solutions to overcome the limitations associated with conventional drug delivery systems, such as poor bioavailability, lack of target specificity, rapid elimination, systemic toxicity, and drug residue concerns in food-producing animals. Nanotechnology-based drug delivery systems improve therapeutic efficacy by enhancing drug solubility, stability, controlled release, and targeted delivery.
Various nanocarriers, including liposomes, polymeric nanoparticles, solid lipid nanoparticles, nanoemulsions, dendrimers, quantum dots, magnetic nanoparticles, nanoshells, and nanopores, have shown significant applications in veterinary therapeutics, diagnostics, oncology, vaccine delivery, and infectious disease management. These nanosystems improve the pharmacokinetic and pharmacodynamic properties of drugs while minimizing adverse effects.
Despite their advantages, nanotechnology-based products raise important safety and toxicological concerns. The unique physicochemical properties of nanoparticles may result in organ toxicity, immunotoxicity, reproductive toxicity, oxidative stress, and environmental hazards. Species-specific responses and long-term exposure effects further complicate safety evaluation in veterinary applications. Therefore, comprehensive nanotoxicological assessment and regulatory oversight are essential before widespread adoption.
The future prospects of nanotechnology in veterinary pharmacology and toxicology include the development of smart nanocarriers, nano-theranostics, nano-phytogenics, precision veterinary medicine, and environmentally safer nanomaterials. This review consolidates findings from multiple scientific studies to present a comprehensive overview of the current applications, safety issues, and future prospects of nanotechnology in veterinary pharmacology and toxicology (Alivisatos, 2004; McNeil, 2009; Patra et al., 2018).
Keywords
Download Options
Introduction
Veterinary pharmacology and toxicology form the foundation of effective disease prevention, treatment, and control in animals. The rational use of drugs in veterinary practice is essential not only for animal health and welfare but also for ensuring food safety and public health. Conventional drug formulations often face several limitations, including poor aqueous solubility, low bioavailability, non-specific distribution, rapid metabolism, and short biological half-life. These drawbacks frequently necessitate higher doses or repeated administration, increasing the risk of toxicity and drug residues in milk, meat, and eggs (Patel et al., 2017).
In recent years, advancements in pharmaceutical sciences have focused on the development of novel drug delivery systems to overcome these challenges. Among these advancements, nanotechnology has gained significant attention due to its ability to modify drug behaviour at the molecular and cellular levels. Nanotechnology involves the design, synthesis, and application of materials with dimensions typically ranging from 1 to 100 nanometers. At this scale, materials exhibit unique physicochemical properties such as increased surface area, enhanced reactivity, altered optical behaviour, and improved interaction with biological membranes (Alivisatos, 2004).
In veterinary pharmacology, nanotechnology provides opportunities to enhance drug absorption, improve tissue targeting, prolong circulation time, and achieve controlled release. Nanocarriers protect drugs from premature degradation and facilitate site-specific delivery, thereby reducing systemic toxicity. In veterinary toxicology, nanotechnology offers tools to study toxicokinetics, minimize adverse drug reactions, and develop safer therapeutic formulations. Additionally, nanotechnology has expanded its applications beyond drug delivery to include diagnostics, imaging, vaccine development, and cancer therapy in animals (McNeil, 2009; Patra et al., 2018).
However, the increasing application of nanomaterials raises concerns regarding their safety. Due to their small size and high reactivity, nanoparticles may cross biological barriers and accumulate in vital organs. Understanding the toxicological implications of nanotechnology is therefore crucial for its safe and responsible application. This review aims to discuss the current applications of nanotechnology in veterinary pharmacology and toxicology, highlight associated safety issues, and explore future prospects in this rapidly evolving field.
Conclusion
Nanotechnology has emerged as a transformative tool in veterinary pharmacology and toxicology by offering innovative solutions to the limitations of conventional drug delivery systems. The application of nanotechnology has significantly improved drug bioavailability, targeting efficiency, controlled release, and therapeutic efficacy across different veterinary species. Nanocarriers such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, nanoemulsions, magnetic nanoparticles, nanoshells, and nanopores have demonstrated promising applications in drug delivery, diagnostics, oncology, vaccine development, and feed supplementation.
From a veterinary toxicology perspective, nanotechnology has contributed to a better understanding of drug-tissue interactions, toxicokinetics, and safety evaluation. However, the unique physicochemical properties of nanomaterials also raise concerns regarding organ toxicity, immunotoxicity, reproductive toxicity, neurotoxicity, and environmental impact. Species-specific responses and long-term exposure effects further emphasize the need for comprehensive safety evaluation and risk assessment before widespread veterinary application.
Future prospects of nanotechnology in veterinary pharmacology and toxicology are highly promising, particularly in the areas of precision veterinary medicine, nano-theranostics, nano-phytogenics, and environmentally safer nanomaterials. Advances in nanotoxicology, regulatory frameworks, and sustainable manufacturing are expected to facilitate safer and more effective use of nanotechnology in veterinary practice. With responsible application, appropriate regulation, and continued research, nanotechnology has the potential to significantly enhance animal health, productivity, food safety, and environmental sustainability.
References
- Alghuthaymi, M. A., Hassan, A. A., Kalia, A., Sayed El Ahl, R. M., El Hamaky, A. A., Oleksak, P., ... & Abd-Elsalam, K. A. (2021). Antifungal nano-therapy in veterinary medicine: Current status and future prospects. Journal of Fungi, *7*(7), 494.
- Alivisatos, A. P. (2004). The use of nanocrystals in biological detection. Nature Biotechnology, *22*(1), 47-52.
- Bilgili, A., & Uysal, M. H. (2019). Use areas of nanotechnology in veterinary medicine. Journal of Food Science and Engineering, *9*, 201-216.
- Carvalho, S. G., Rodrigues, L. R., & Lima, E. (2020). Advances and challenges in nanocarriers for veterinary nanomedicines. Journal of Controlled Release, *327*, 555-568.
- Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021). Nanosafety versus nanotoxicology: Adequate animal models for assessment. Toxicology, *462*, 152957.
- Dhakad, G., Aich, R., Kushwah, M. S., & Yadav, J. S. (2017). Nanotechnology: Trends and future prospective. Global Journal of Bio-Science and Biotechnology, *6*(3), 548-553.
- Feynman, R. P. (1960). There's plenty of room at the bottom. Engineering and Science, *23*(5), 22-36.
- Hill, E. K., & Li, J. (2017). Current and future prospects for nanotechnology in animal production. Journal of Animal Science and Biotechnology, *8*(1), 26.
- Ianiski, L. B., Faccin-Galhardi, L. C., & Gonçalves, J. L. (2022). Nanotechnology in veterinary medicine: Applications and perspectives. Pesquisa Veterinária Brasileira, *42*, e06944.
- McNeil, S. E. (2009). Nanotechnology for the biologist. Journal of Leukocyte Biology, *85*(4), 561-564.
- Mweetwa, L. (2022). Past, present and future perspective of application of nanobiotechnology in pharmacology and innovative therapeutics. Medical Research Archives.
- Patel, K., Patel, M., Patel, N., Patel, D., & Patel, B. (2017). Nanotechnology-based drug delivery systems in veterinary medicine. Veterinary World, *10*(9), 1051-1057.
- Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. P., Acosta-Torres, L. S., ... & Shin, H. S. (2018). Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology, *16*, 71.
- Prasad, R. D., Charmode, N., Shrivastav, O. P., Prasad, S. R., Moghe, A., Sarvalkar, P. D., & Prasad, N. R. (2021). A review on concept of nanotechnology in veterinary medicine. ES Food & Agroforestry, *4*(5), 28-60.
- Sapino, S., Chirio, D., Peira, E., & Gallarate, M. (2022). Nanocarriers in veterinary medicine: A challenge for translation. Pharmaceutics, *14*(1), 45.
- Singh, A. V. (2019). Review of emerging concepts in nanotoxicology. Nanotoxicology, *13*(1), 1-23.
- Taniguchi, N. (1974). On the basic concept of nanotechnology. In Proceedings of the International Conference on Production Engineering (pp. 18-23). Tokyo, Japan.
- Trif, E., Cerbu, C., Olah, D., Zăblău, S. D., Spînu, M., Potârniche, A. V., & Brudașcă, F. (2023). Old antibiotics can learn new ways: A systematic review of florfenicol use in veterinary medicine and future perspectives using nanotechnology. Animals, *13*(10), 1695.
- Woldeamanuel, K. M., Kurra, F. A., & Roba, Y. T. (2021). A review on nanotechnology and its application in modern veterinary science. International Journal of Nanomaterials, Nanotechnology and Nanomedicine, *7*(1), 026-031.
- Youssef, F. S., El-Banna, H. A., Elzorba, H. Y., & Galal, A. M. (2019). Application of some nanoparticles in the field of veterinary medicine. International Journal of Veterinary Science and Medicine, *7*(1), 78-93.
- Zhou, Y., Guo, L., Dai, G., Li, B., Bai, Y., Wang, W., & Zhang, J. (2024). An overview of polymeric nanoplatforms to deliver veterinary antimicrobials. Nanomaterials, *14*(4), 341.